- HPLC purity ≥99%, with a COA for each lot on request
- Certificate of analysis tied to your lot number
- Tracked EU delivery, dispatched the next working day
ARA-290 (Cibinetide)
Cibinetide — 11-amino-acid peptide mimicking erythropoietin helix B, for research
In stock2 formats availableCAS 1208243-50-8
€85Range €85 – €153
This listing is currently unavailable. Contact us and we will tell you when it is back or suggest an equivalent.
Ask about this listing or request its COA- FormLyophilized powder, sealed glass vial with crimped stopper
- Mol. weight1259.34 g/mol
- Research areasSmall-fibre neuropathy, neuropathic pain, sarcoidosis, inflammatory and ischaemic models
For laboratory research use only. Sold exclusively for in-vitro laboratory research by qualified professionals. Not for human or veterinary use, and not a medicine, food, cosmetic or dietary supplement. Terms and Conditions
Overview
Key facts
ARA-290, or cibinetide, is an 11-residue peptide patterned on the outward-facing surface of helix B in erythropoietin.
- CAS number
- 1208243-50-8
- Molecular formula
- C51H84N14O21
- Molecular weight
- 1259.34 g/mol
- Amino acid sequence
- Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
- Purity
- ≥99% by HPLC; lot-matched COA available
- Form
- Lyophilized powder, sealed glass vial with crimped stopper
- Storage
- −20 °C, sealed and protected from light and moisture
- Available sizes
- 10 mg · 20 mg
For research use only. Not for human consumption.
ARA-290, or cibinetide, is an 11-residue peptide patterned on the outward-facing surface of helix B in erythropoietin. EPO has two separate activity profiles: the well-known blood-forming one, which runs through the classical receptor homodimer, and a tissue-protective one ascribed to a complex of the EPO receptor with the beta-common receptor — the so-called innate repair receptor. ARA-290 was engineered to activate the latter while leaving the former alone.
This design goal explains why the peptide keeps turning up in studies of neuroprotection and inflammation instead of haematology. Its sequence comes from a surface patch of EPO that plays no part in binding the classical receptor, and published studies report no relevant change in red-cell production — eliminating a significant confounder in tissue-protection work.
Our material is produced by solid-phase synthesis, purified to ≥99% by reversed-phase HPLC and delivered as lyophilised powder in sealed 10 mg and 20 mg glass vials, each lot backed by its own certificate of analysis. Research has focused on small-fibre neuropathy, neuropathic pain and models of inflammation. Supplied for laboratory research use only.
Specifications
Identity
- CAS number
- 1208243-50-8
- Molecular formula
- C51H84N14O21
- Molecular weight
- 1259.34 g/mol
- Amino acid sequence
- Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
- Chain length
- 11 amino acids, N-terminal pyroglutamate
- Peptide class
- Erythropoietin-derived tissue-protective peptide
Supply & purity
- Form
- Lyophilized powder, sealed glass vial with crimped stopper
- Purity
- ≥99% by HPLC; lot-matched COA available
- Available sizes
- 10 mg, 20 mg
Handling & storage
- Storage (lyophilized)
- −20 °C, sealed and protected from light and moisture
Additional detail
- Other names
- Cibinetide, pyroglutamate helix-B surface peptide (pHBSP)
- Proposed target
- Innate repair receptor (EPOR/CD131 heterocomplex)
- Research areas
- Small-fibre neuropathy, neuropathic pain, sarcoidosis, inflammatory and ischaemic models
Questions about ARA-290 (Cibinetide)
What is ARA-290?
ARA-290 (cibinetide) is a synthetic 11-amino-acid peptide derived from the outer surface of erythropoietin's helix B. We supply it as a lyophilised research powder; it is studied for signalling through the innate repair receptor, not for effects on red-cell formation.
Does it increase red blood cell counts the way EPO does?
According to published data, no. Its sequence comes from an EPO surface region that does not take part in binding the classical homodimer receptor that drives blood-cell formation — exactly why researchers choose it for tissue-protection studies, where erythropoietic effects would distort the data.
Do you supply a certificate of analysis?
Yes. Every lot is analysed by reversed-phase HPLC to ≥99% purity with identity confirmed by mass spectrometry. The certificate bearing the lot number on your vial can be requested before or after you order.
What storage does ARA-290 need?
Store the unopened lyophilised vial at −20 °C, dry and protected from light. Once reconstituted, keep the solution at 2–8 °C in the dark and use it within your planned study period; aliquot it first so it does not go through repeated freezing and thawing.
